marvel super heroes video game

marvel super heroes video game The Zen Ten - My Top Picks For 2025'Tweaked land laws to be introduced in Uttarakhand assembly in next session'

“The air traffic control tower, the departure lounge — just a few metres from where we were — and the runway were damaged,” Tedros Adhanom Ghebreyesus said on the social media platform X. He added that he and UN colleagues were safe. “We will need to wait for the damage to the airport to be repaired before we can leave,” he said. UN spokesperson Stephanie Tremblay later said the injured person was with the UN Humanitarian Air Service. Israel’s army later told The Associated Press it was not aware that the WHO chief was at the location in Yemen. The Israeli strikes followed several days of Houthi launches setting off sirens in Israel. The Israeli military in a statement said it attacked infrastructure used by the Iran-backed Houthis at the international airport in Sanaa and ports in Hodeida, Al-Salif and Ras Qantib, along with power stations, asserting they were used to smuggle in Iranian weapons and for the entry of senior Iranian officials. Israel’s military added it had “capabilities to strike very far from Israel’s territory — precisely, powerfully, and repetitively”. The strikes, carried out over 1,000 miles from Jerusalem, came a day after Prime Minister Benjamin Netanyahu said “the Houthis, too, will learn what Hamas and Hezbollah and Assad’s regime and others learned” as his military has battled those more powerful proxies of Iran. The Houthi-controlled satellite channel al-Masirah reported multiple deaths and showed broken windows, collapsed ceilings and a bloodstained floor and vehicle. Iran’s foreign ministry condemned the strikes. The US military has also targeted the Houthis in recent days. The UN has said the targeted ports are important entry points for humanitarian aid for Yemen, the poorest Arab nation that plunged into a civil war in 2014. Over the weekend, 16 people were wounded when a Houthi missile hit a playground in the Israeli city of Tel Aviv, while other missiles and drones have been shot down. Last week, Israeli jets struck Sanaa and Hodeida, killing nine people, calling it a response to previous Houthi attacks. The Houthis also have been targeting shipping on the Red Sea corridor in what it says is an act of solidarity with Palestinians in Gaza. The UN Security Council has an emergency meeting on Monday in response to an Israeli request that it condemn the Houthi attacks and Iran for supplying them with weapons.The US government has awarded Intel a whopping $7.85 billion in CHIPS Act funding, as part of its plan to boost domestic semiconductor manufacturing. This is the biggest award under the CHIPS Act to date, although it is less than the maximum $8.5 billion allocated for Intel in March this year. White House's Deputy Chief of Staff Natalie Quillian announced it, calling it an important step in implementing President Joe Biden's CHIPS and Science Act and Investing in America agenda. Expansion plans and job creation The CHIPS investment will go into building and expanding Intel's semiconductor fabrication plants in Arizona, New Mexico , Ohio , as well as Oregon. This expansion is expected to create as many as 30,000 jobs in these four states. According to The Wall Street Journal , Intel will get at least $1 billion in funds later this year. In exchange for the funding, the chipmaker has promised no stock buybacks for five years. Separate $3B contract and project timeline extensions According to The New York Times , the funding was cut because Intel had secured a separate $3 billion contract in September. This contract involves the development of chips for national security products as well as military applications for the US government. Some of Intel's project timelines also extended beyond a 2030 government deadline, which contributed to the funding cut. Revised investment plans and job estimates Despite the funding, Intel has adjusted some of its plans. The company's expansion in Ohio will now generate 3,500 lesser jobs than the previously estimated 10,000. Additionally, Intel has reduced its planned US manufacturing investments from $100 billion over five years, to $90 billion by the end of this decade. These changes come amid difficulties with its next-gen 18A manufacturing process, and a record quarterly loss of $16.6 billion - the largest since its founding in 1968. Intel's decision to not finalize a separate $11B loan Intel has decided against finalizing a separate $11 billion low-cost government loan that was offered in March. The company said today that the loan terms "were less favorable than anticipated for Intel's shareholders and did not align with Intel's long-term growth and market interests." It said it would discuss utilizing loan provisions with the incoming administration in the future.

‘General Hospital’ Alum Ingo Rademacher Reignites Legal Battle With ABC After Steve Burton’s Return

Court Docs: Seattle-Area Teens Tied 14-Year-Old Victim to Tree Before Disemboweling Him

Obituary: veteran TV3 news journalist Bob McNeil diesJERUSALEM — The ceasefire between Israel and Lebanon’s Hezbollah militants began early Wednesday as a region on edge wondered whether it will hold. The ceasefire announced Tuesday is a major step toward ending nearly 14 months of fighting sparked by the ongoing war in Gaza between Israel and Hamas. Israel said it will attack if Hezbollah breaks the ceasefire agreement. The ceasefire calls for an initial two-month halt to fighting and requires Hezbollah to end its armed presence in southern Lebanon, while Israeli troops are to return to their side of the border. An international panel led by the United States will monitor compliance. The ceasefire began at 4 a.m. Wednesday, a day after Israel carried out its most intense wave of airstrikes in Beirut since the start of the conflict that in recent weeks turned into all-out war. At least 42 people were killed in strikes across the country, according to local authorities. Smoke rises following an Israeli airstrike on Dahiyeh, in Beirut, Lebanon, Tuesday, Nov. 26, 2024. The ceasefire does not address the devastating war in Gaza , where Hamas is still holding dozens of hostages and the conflict is more intractable. There appeared to be lingering disagreement over whether Israel would have the right to strike Hezbollah if it believed the militants had violated the agreement, something Prime Minister Benjamin Netanyahu insisted was part of the deal but which Lebanese and Hezbollah officials have rejected. Israel's security Cabinet approved the U.S.-France-brokered ceasefire agreement after Netanyahu presented it, his office said. U.S. President Joe Biden, speaking in Washington, called the agreement “good news” and said his administration would make a renewed push for a ceasefire in Gaza. The Biden administration spent much of this year trying to broker a ceasefire and hostage release in Gaza but the talks repeatedly sputtered to a halt . President-elect Donald Trump has vowed to bring peace to the Middle East without saying how. Still, any halt to the fighting in Lebanon is expected to reduce the likelihood of war between Israel and Iran, which backs both Hezbollah and Hamas and exchanged direct fire with Israel on two occasions earlier this year. Israel says it will ‘attack with might’ if Hezbollah breaks truce Netanyahu presented the ceasefire proposal to Cabinet ministers after a televised address in which he listed accomplishments against Israel’s enemies across the region. He said a ceasefire with Hezbollah would further isolate Hamas in Gaza and allow Israel to focus on its main enemy, Iran. “If Hezbollah breaks the agreement and tries to rearm, we will attack,” he said. “For every violation, we will attack with might.” The ceasefire deal calls for a two-month initial halt in fighting and would require Hezbollah to end its armed presence in a broad swath of southern Lebanon, while Israeli troops would return to their side of the border. Thousands of additional Lebanese troops and U.N. peacekeepers would deploy in the south, and an international panel headed by the United States would monitor compliance. Biden said Israel reserved the right to quickly resume operations in Lebanon if Hezbollah breaks the terms of the truce, but that the deal "was designed to be a permanent cessation of hostilities.” A police bomb squad officer inspects the site where a rocket fired from Lebanon landed in a backyard in Kiryat Shmona, northern Israel, Tuesday Nov. 26, 2024. Netanyahu’s office said Israel appreciated the U.S. efforts in securing the deal but “reserves the right to act against every threat to its security.” Lebanon’s caretaker Prime Minister Najib Mikati welcomed the ceasefire and described it as a crucial step toward stability and the return of displaced people. Hezbollah has said it accepts the proposal, but a senior official with the group said Tuesday it had not seen the agreement in its final form. “After reviewing the agreement signed by the enemy government, we will see if there is a match between what we stated and what was agreed upon by the Lebanese officials,” Mahmoud Qamati, deputy chair of Hezbollah’s political council, told the Al Jazeera news network. “We want an end to the aggression, of course, but not at the expense of the sovereignty of the state," he said, referring to Israel's demand for freedom of action. “Any violation of sovereignty is refused.” Warplanes bombard Beirut and its southern suburbs Even as ceasefire efforts gained momentum in recent days, Israel continued to strike what it called Hezbollah targets across Lebanon while the militants fired rockets, missiles and drones across the border. An Israeli strike on Tuesday leveled a residential building in central Beirut — the second time in recent days warplanes have hit the crowded area near downtown. At least seven people were killed and 37 wounded, according to Lebanon's Health Ministry. Israel also struck a building in Beirut's bustling commercial district of Hamra for the first time, hitting a site around 400 meters (yards) from Lebanon’s Central Bank. There were no reports of casualties. The Israeli military said it struck targets linked to Hezbollah's financial arm. The evacuation warnings covered many areas, including parts of Beirut that previously were not targeted. Residents fled. Traffic was gridlocked, with mattresses tied to some cars. Dozens of people, some wearing pajamas, gathered in a central square, huddling under blankets or standing around fires as Israeli drones buzzed overhead. Israeli military spokesman Avichay Adraee issued evacuation warnings for 20 buildings in Beirut's southern suburbs, where Hezbollah has a major presence, as well as a warning for the southern town of Naqoura where the U.N. peacekeeping mission, UNIFIL, is headquartered. UNIFIL spokesperson Andrea Tenenti said peacekeepers will not evacuate. Israeli soldiers inspect the site Tuesday Nov. 26, 2024, where a rocket fired from Lebanon landed in a backyard in Kiryat Shmona, northern Israel. Israeli forces reach Litani River in southern Lebanon The Israeli military also said its ground troops clashed with Hezbollah forces and destroyed rocket launchers in the Slouqi area on the eastern end of the Litani River, a few kilometers (miles) from the Israeli border. Under the ceasefire deal, Hezbollah is required to move its forces north of the Litani, which in some places is about 30 kilometers (20 miles) north of the border. Hezbollah began firing into northern Israel on Oct. 8, 2023, saying it was showing support for the Palestinians, a day after Hamas carried out its attack on southern Israel, triggering the Gaza war. Israel returned fire on Hezbollah, and the two sides have exchanged barrages ever since. Israel escalated its bombardment in mid-September and later sent troops into Lebanon, vowing to put an end to Hezbollah fire so tens of thousands of evacuated Israelis could return to their homes. Israeli security officers and army soldiers inspect the site Tuesday Nov. 26, 2024, where a rocket fired from Lebanon landed in a backyard in Kiryat Shmona, northern Israel. More than 3,760 people have been killed by Israeli fire in Lebanon the past 13 months, many of them civilians, according to Lebanese health officials. The bombardment has driven 1.2 million people from their homes. Israel says it has killed more than 2,000 Hezbollah members. Hezbollah fire has forced some 50,000 Israelis to evacuate in the country’s north, and its rockets have reached as far south in Israel as Tel Aviv. At least 75 people have been killed, more than half of them civilians. More than 50 Israeli soldiers have died in the ground offensive in Lebanon. Chehayeb and Mroue reported from Beirut and Federman from Jerusalem. Associated Press reporters Lujain Jo and Sally Abou AlJoud in Beirut and Aamer Madhani in Washington contributed. Copyright 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission. Respond: Write a letter to the editor | Write a guest opinion Subscribe to stay connected to Tucson. A subscription helps you access more of the local stories that keep you connected to the community. Get Government & Politics updates in your inbox! Stay up-to-date on the latest in local and national government and political topics with our newsletter.Miracle Alzheimer's drug which could slow down the disease is being considered for use on the NHS - giving hope to millions of people By KATE PICKLES HEALTH CORRESPONDENT FOR THE DAILY MAIL Published: 16:07 EST, 29 December 2024 | Updated: 16:22 EST, 29 December 2024 e-mail View comments A daily pill which could be the first to slow Alzheimer’s disease is being considered for use on the NHS . Officials are assessing whether hydromethylthionine mesylate (HMTM) shows sufficient promise to be given the green light for NHS patients. The drug attacks a protein called tau which accumulates in tangles in the brain, affecting memory and cognition. Taken as a tablet, it would not require the complex infusions needed for other recent breakthrough Alzheimer’s treatments. Early trial data suggests it can slow progression of the disease with regulators set to make a decision as soon as April. If approved, it would mark the biggest milestone for the disease in decades, bringing hope to millions worldwide. Alzheimer’s disease is the most common cause of dementia and is set to affect more than a million Britons by the middle of this century. But there is growing hope the NHS must get ready for a future where it is treatable and even curable. A daily pill which could be the first to slow Alzheimer’s disease is being considered for use on the NHS (stock image) Officials are assessing whether hydromethylthionine mesylate (HMTM) shows sufficient promise to be given the green light for NHS patients (stock image) Developed by Aberdeen-based TauRX, early trials suggested the medication leads to sustained cognitive improvement at an early, clinically detectable stage of Alzheimer’s. The experimental compound belongs to a class of drugs known as tau aggregation inhibitors, which is hoped can undo the tangles, slowing and potentially altogether stopping memory loss. Former NHS clinical director for dementia and emeritus professor at the University of Manchester, Professor Alistair Burns, said it was potentially ‘great news for people with Alzheimer’s disease, their families and carers’. ‘We have reached an exciting time in the field of Alzheimer’s disease treatment,’ he told the Telegraph. ‘After no new therapies for a generation, we are on the threshold of having a range of new treatments, including a tau-targeted oral therapy, which have the real potential to slow the disease process.’ Read More BREAKING NEWS Anger as NHS patients told they WON'T get 'new hope' Alzheimer's drug donanemab The decision will follow the mixed fortunes of two breakthrough drugs for Alzheimer’s drugs - Lecanemab and Donanemab - having with UK regulators. Despite both being given the green light by the Medicines and Healthcare products Regulatory Agency (MHRA), hope was quickly extinguished when health spending watchdog National Institute of Health and Care Excellence (NICE) found they were not value for money for the NHS. Some experts question the potential benefits of HMTM, with the latest data yet to be peer-reviewed. Findings presented at the Alzheimer’s Disease International conference this year showed little or no benefit over placebo on memory and cognitive decline in people with Alzheimer’s disease. But the company said it was due to the unexpected effects of the placebo and is understood to be offering further evidence and results. The drug also appears to have a better safety profile than others coming through, suggesting it is less likely to cause adverse side effects. Dr Richard Oakley, the associate director of research and innovation at the charity Alzheimer’s Society, said: ‘Although the placebo was expected to have no effect at the dose it was given, it built up in participants’ bodies over time. ‘However, HMTM did reduce the levels of a marker of brain cell loss.’ He added: ‘In a small subset of participants with mild cognitive impairment who have features of Alzheimer’s disease in their brains, HMTM seemed to have a beneficial effect.’ The MHRA, NICE and TauRX were all approached for comment. NHS Share or comment on this article: Miracle Alzheimer's drug which could slow down the disease is being considered for use on the NHS - giving hope to millions of people e-mail Add comment

No. 24 Illinois stuns Rutgers on Bryant's 40-yard TD reception with 4 seconds leftMashburn scores 18 as Temple beats Buffalo 91-71

Former Kentucky WR Dane Key set for transfer to NebraskaFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Lilium To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in Lilium between June 11, 2024 and November 3, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310) . [You may also click here for additional information] NEW YORK, Dec. 26, 2024 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP , a leading national securities law firm, is investigating potential claims against Lilium N.V. (“Lilium” or the “Company”) (NASDAQ: LILM) and reminds investors of the January 6, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com . As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) Defendants overstated the progress of the Company’s fundraising activities; (2) Defendants overstated the likelihood and/or feasibility of obtaining sufficient funding to continue operations; (3) Defendants failed to sufficiently disclose the imminent insolvency of the Company and its subsidiaries; and (4) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis. On October 24, 2024, before the market opened, Lilium disclosed that it had been unable to raise sufficient additional funds to continue the operations of the Company's principal operating wholly owned German subsidiaries. As a result, the managing directors of the subsidiaries determined that they are overindebted and are, or will, become unable to pay their existing liabilities. The Company disclosed that, subject to certain limited exceptions, the Company will lose control of the subsidiaries. On this news, Lilium's stock price fell $0.33, or 61.6%, to close at $0.21 per share on October 24, 2024, on unusually heavy trading volume. The Company's stock price continued to fall in the subsequent trading day, falling $0.06, or 28.8%, to close at $0.15 per share on October 25, 2024, on unusually heavy trading volume. Then, on November 4, 2024, before the market opened, the Company reported that, following the insolvency of the Company's subsidiaries, Lilium had not been able to raise sufficient additional funds to conduct its ongoing business consistent with past practice. The Company disclosed that "funding for the Company is not feasible." As a consequence, the Company would be "obliged to file for insolvency." On this news, Lilium's stock price fell $0.015, or 15.5%, to close at $0.083 per share on November 4, 2024, on unusually heavy trading volume. The Company's stock price continued to fall in the subsequent trading day, falling $0.031, or 36.97%, to close at $0.052 per share on November 5, 2024, on unusually heavy trading volume. The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not. Faruqi & Faruqi, LLP also encourages anyone with information regarding Lilium’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others. To learn more about the Lilium N.V. class action, go to www.faruqilaw.com/LILM or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310) . Follow us for updates on LinkedIn , on X , or on Facebook . Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner. A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/c27c0b77-4720-4e5d-8a4d-69609ae3e05dFlag football scours nation with talent camps to uncover next wave of starsNEW YORK , Dec. 24, 2024 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of all purchasers of common stock of MGP Ingredients, Inc. (NASDAQ: MGPI) between May 4, 2023 and October 30, 2024 . A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than February 14, 2025 . Javascript is required for you to be able to read premium content. Please enable it in your browser settings.